Read from its own SEC filings · nothing written, nothing inferred

60 Degrees Pharmaceuticals $SXTP

🫧 Edgar looked up 60 DEGREES PHARMACEUTICALS, INC. ($SXTP). Last filing: 8-K (8.01 Other Events), 2026-09-14. 16 event filings (8-K) in the past twelve months.

🔖 Exposure: revenue $1.0M (FY2025), total debt $153K. Experience: revenue up 65.5% on the year, up 65.1% a year over 3 years; operating margin -771.6%, up from -1599.0%. Soundness: equity 64.5% of assets, return on equity -212.8%. Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $1.2M and $2.2M next year (method v3, set from 749 SEC company-years; on a year the method never saw, 83% landed inside). A range, not a forecast. Against peers (114 filers, $50M+ revenue, pharmaceutical preparations): operating margin -771.6% against a -3.8% median; growth 65.5% against 13.7%.

60 DEGREES PHARMACEUTICALS, INC. against its own record and its peers
Operating marginPeer median -3.8%-771.6%Revenue, on the yearPeer median 13.7%65.5%Equity of assetsPeer median 40.3%64.5%Return on equityPeer median -1.1%-212.8%Gold tick: the median of 100–118 peers with $50M+ revenue in pharmaceutical preparations

The figures, as filed

Fiscal year end2025-12-31
Revenue$1M
Revenue, on the year65.5%
Revenue, a year over the record65.1%
Operating margin−771.6%
Operating margin, prior year−1599.0%
Net margin−732.8%
Research and development$2M · 209.5% of revenue
Free cash flow−$7M
Cash$2M
Total debt$0M
Equity of assets64.5%
Return on equity−212.8%
Payout of profit
Dividend per share
Audited years read4

Peers: the median of 114 filers with $50M+ revenue in pharmaceutical preparations.

Recent filings

Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price. Reporting, not investment advice. No price targets, no buy or sell views. Figures from the SEC’s own data · every filing · this page as JSON · ask about another company

1 · Watch

Tell me when they file

Or tap watch on any row above. One note the day they file, from Edgar, each with a one-click stop link. Handled to EU GDPR and Japan APPI standards.

On Bluesky: follow Edgar & Edgarette.

2 · Price it

A new leader’s rebrand and launch

Priced live by the same engine as our estimator, from the catalogue at wholesale.

Price the printing · Open the full estimator

✦ Build the kit yourself
3 · Confirm

Check it with Jenny

Most buyers check what they found, or what their AI found, with one person before they commit. That person is the principal.

Jenny Huang Goodman MPA MSc MHSA, Principal

Book a time (757) 390-0424
Free · unsponsored · source-linked

Clean data. No ads. Not now, not later.

Nine boards reading every SEC filing the day it lands, ten editorial desks publishing daily, an open endpoint other AIs can query, and a 70,000-product house behind all of it. This is the public record end of it.

Every row is a filing.Straight from the company's own SEC document, linked. Nothing written, nothing inferred.
Nobody is watching you read.No ad trackers, no cookies from us. Our page counts are cookieless.
One email, one job.Watch a company and we hold that address for the alert alone. One tap ends it. Never sold, never shared.
The house pays for this.Corporate event programs, corporate supplies and branded merchandise, since 1997. That is what funds the desks, under the house's own vendor standards.
Free to reuse with credit · CC BY 4.0 · how the boards are built